Connect Conference & Show Floor Educational Sessions

View, browse and sort the list of Connect Conference sessions and show floor programming by pass type, track, and format. Please note, all Connect Conference delegates have access to CPhI Connect and InformEx Connect programming. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

To learn more about the Connect Conference program, click here.

All SessionsSpeakersMy Schedule
View Sessions As:
  
  • Michael J. Hageman, Ph.D.Former Exec. Dir. of Discovery PharmaceuticsBristol-Myers Squibb

    Dr. Hageman has over 30 years of experience within the pharmaceutical industry, including Upjohn, Pharmacia, Pfizer and for the last 11 years, Bristol-Myers Squibb. He has worked with Discovery organizations for the design and selection of developable molecules, both small drug-like molecules and larger protein biologics. Physicochemical property prediction and characterization, including preformulation and design of enabled formulations for enhanced bioavailability, were critical for successful progression of the drug candidates. He obtained his BS in Pharmacy and PhD in Pharmaceutical Chemistry from the University of Kansas. He has been an adjunct professor at Purdue University, University of Kansas, and University of Utah, serving on 6 different thesis committees. Dr. Hageman is an editor for the Journal of Pharmaceutical Sciences and chairs the Pharmaceutics Advisory Committee for PhRMA Foundation. He has also served as Chair of the Physical Pharmacy and Biopharmaceutics Section for AAPS and been involved in the organization of over 10 symposia at AAPS sponsored meetings. He has nearly 50 publications, 12 patents/applications, 80 invited presentations and over 65 meeting presentations. He has co-edited two books entitled Prodrugs: Challenges and Rewards and Optimizing the Drug-Like Properties of Leads in Drug Discovery.


    Presenting: